Triombrin en es it fr

Triombrin Brand names, Triombrin Analogs

Triombrin Brand Names Mixture

  • No information avaliable

Triombrin Chemical_Formula


Triombrin RX_link

No information avaliable

Triombrin fda sheet

Triombrin msds (material safety sheet)

Triombrin Synthesis Reference

No information avaliable

Triombrin Molecular Weight

241.247 g/mol

Triombrin Melting Point

250-255 oC (hydrochloride salt)

Triombrin H2O Solubility

>20 mg/mL (dichloride salt)

Triombrin State


Triombrin LogP


Triombrin Dosage Forms

No information avaliable

Triombrin Indication

For the treatment of tetrahydrobiopterin (BH4) deficiency.

Triombrin Pharmacology

Tetrahydrobiopterin (BH4) is used to convert several amino acids, including phenylalanine, to other essential molecules in the body including neurotransmitters. Tetrahydrobiopterin deficiency can be caused by mutations in GTP cyclohydrolase 1 (GCH1), 6-pyruvoyl-tetrahydropterin synthase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (PCBD1), 6-pyruvoyltetrahydropterin synthase (PTS), and quinoid dihydropteridine reductase (QDPR) genes. These genes make the enzymes that are critical for producing and recycling tetrahydrobiopterin. If one of the enzymes fails to function correctly because of a gene mutation, little or no tetrahydrobiopterin is produced. As a result, phenylalanine from the diet builds up in the bloodstream and other tissues and can damage nerve cells in the brain. High levels of phenylalanine can result in signs and symptoms ranging from temporary low muscle tone to mental retardation, movement disorders, difficulty swallowing, seizures, behavioral problems, progressive problems with development, and an inability to control body temperature.

Triombrin Absorption

No information avaliable

Triombrin side effects and Toxicity

No information avaliable

Triombrin Patient Information

No information avaliable

Triombrin Organisms Affected

Humans and other mammals